Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE-MeVO
NCT07776873Phase 3Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Oct 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human prourokinase in ischemic stroke, sponsored by First Affiliated Hospital of Anhui Medical University. Started Oct 2026; status: recruiting.
02
Drugs
recombinant human prourokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07776873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07776873.